Identifying market risk for substandard and falsified medicines: an analytic framework based on qualitative research in China, Indonesia, Turkey and Romania [version 1; peer review: 3 approved] [PDF]
Introduction: Substandard and falsified medicines undermine health systems. We sought to unravel the political and economic factors which drive the production of these products, and to explain how they reach patients.
Elizabeth Pisani +5 more
doaj +2 more sources
Countering counterfeits: The role of nurse practitioners in the fight against substandard and falsified medicines. [PDF]
Substandard and falsified (SF) medicines, also referred to as counterfeit drugs, represent a global public health emergency. These products range from drugs with no or little active ingredient to medicines laced with illicit fentanyl. Counterfeits can be copies of brand, generic, or over-the-counter medicines.
Rusatira JC, Ahmed S.
europepmc +4 more sources
Substandard and falsified medicines in the UK: a retrospective review of drug alerts (2001-2011). [PDF]
ObjectiveTo determine the extent of substandard and falsified medicines in the UK.DesignA retrospective review of drug alerts and company-led recalls.SettingThe Medicines and Healthcare Products Regulatory Agency (MHRA) website search for drug alerts issued between 2001 and 2011.Eligibility criteriaDrug alerts related to quality defect in medicinal ...
Almuzaini T, Sammons H, Choonara I.
europepmc +5 more sources
The urgent need for African research collaboration on medicine quality [PDF]
Substandard and falsified medicines threaten African health systems, yet research on this crisis is fragmented and concentrated in few countries, predominantly led by Global North institutions.
Fanqi Zeng +4 more
doaj +2 more sources
Antimicrobial Resistance and Substandard and Falsified Medicines: The Case of HIV/AIDS. [PDF]
Suthar AB, Coggin W, Raizes E.
europepmc +4 more sources
Substandard and falsified medicines (SF medicines) pose a severe threat to population health and safety. China has a large proportion of SF medicines, imposing a heavy economic burden and exacerbating inequities in access to quality medications ...
Tangsiwei Xin
exaly +3 more sources
Screening for substandard and falsified medicines in Nigeria using visual inspection and GPHF-Minilab analysis: lessons learnt for future training of health workers and pharmacy personnel [PDF]
Lutz Heide
exaly +2 more sources
Knowledge, attitudes and practices on substandard and falsified medicines for human and animal use in Wakiso district, Uganda [PDF]
Linda Gibson +2 more
exaly +2 more sources
The prevalence of substandard and falsified medicines in low- and middle-income countries (LMICs) is a major global public health concern. Multiple screening technologies for post-market surveillance of medicine quality have been developed but there ...
Colleen R. Higgins +2 more
doaj +2 more sources
Community pharmacy professionals’ knowledge, attitudes, and practices toward substandard and falsified medicines and associated factors in Bahir Dar City, Northwest Ethiopia [PDF]
Yeniewa Kerie Anagaw +2 more
exaly +2 more sources

